Ten‐year efficacy and safety of tenofovir disoproxil fumarate treatment for chronic hepatitis B virus infection-Reference-Cited by-同舟云学术

Ten‐year efficacy and safety of tenofovir disoproxil fumarate treatment for chronic hepatitis B virus infection

Published:2019-07-10 Issue:10 Volume:39 Page:1868-1875
ISSN:1478-3223
Container-title:Liver International
language:en
Short-container-title:Liver Int

Author:

Marcellin Patrick¹^ORCID,Wong David K²,Sievert William³,Buggisch Peter⁴,Petersen Jörg⁴,Flisiak Robert⁵,Manns Michael⁶⁷,Kaita Kelly⁸,Krastev Zahari⁹,Lee Samuel S¹⁰,Cathcart Andrea L¹¹,Crans Gerald¹¹,Op den Brouw Marjoleine¹²,Jump Belinda¹¹,Gaggar Anuj¹¹,Flaherty John¹¹,Buti Maria¹³

Affiliation:

1. Viral Hepatitis Research Unit Hôpital Beaujon Clichy France

2. Toronto Centre for Liver Disease University Health Network, University of Toronto Toronto Ontario Canada

3. Gastroenterology and Hepatology Unit Monash Health and Monash University Melbourne Australia

4. Liver Unit, IFI‐Institute for Interdisciplinary Medicine Asklepios Klinik St Georg Hamburg Germany

5. Department of Infectious Diseases and Hepatology Medical University Bialystok Bialystok Poland

6. Department of Gastroenterology, Hepatology, and Endocrinology Hannover Medical School Hannover Germany

7. Helmholtz Center for Infection Research (HZI) Hannover Germany

8. Viral Hepatitis Investigative Unit University of Manitoba Winnipeg Canada

9. Clinic of Gastroenterology St Ivan Rilsky University Hospital, Medical University Sofia Bulgaria

10. Liver Unit University of Calgary Calgary Alberta Canada

11. Gilead Sciences Inc Foster City California

12. Gilead Sciences Europe Ltd Uxbridge UK

13. Liver Unit Hospital Universitario Vall d’Hebron and CIBEREHD del Instituto Carlos III Barcelona Spain

Funder

Gilead Sciences

Publisher

Wiley

Subject

Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/liv.14155

Reference34 articles.

1. World Health Organization.Guidelines on hepatitis B and C testing 2017.http://apps.who.int/iris/bitstream/10665/254621/1/9789241549981-eng.pdf?ua=1. Accessed February 18 2019.

2. Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance

3. EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection

4. Tenofovir Disoproxil Fumarate versus Adefovir Dipivoxil for Chronic Hepatitis B

5. Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study

Cited by 102 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Persistent hiccups due to aripiprazole: a case report and review of the literature;Frontiers in Pharmacology;2024-01-05

2. A novel nomogram for predicting HBeAg seroclearance in HBeAg-positive chronic hepatitis B patients treated with nucleos(t)ide analogues;Annals of Hepatology;2024-01

3. Factors Associated with Renal Impairment in Patients on Tenofovir for Chronic Hepatitis B in Yaoundé (Cameroon);Open Journal of Gastroenterology;2024

4. Gene-Editing and RNA Interference in Treating Hepatitis B: A Review;Viruses;2023-12-08

5. Hepatitis B Virus and microRNAs: A Bioinformatics Approach;International Journal of Molecular Sciences;2023-12-07